|
|
Volumn 19, Issue 9, 2001, Pages 819-822
|
|
Monoclonal antibodies in the clinic
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GROWTH (MATERIALS);
MONOCLONAL ANTIBODIES;
TEETHING PROBLEMS;
BIOTECHNOLOGY;
ABCIXIMAB;
ALEMTUZUMAB;
CHIMERIC ANTIBODY;
GEMTUZUMAB OZOGAMICIN;
HUMAN MONOCLONAL ANTIBODY;
INFLIXIMAB;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MONOCLONAL ANTIBODY;
OKT 3;
ORTHOCLONE;
PALIVIZUMAB;
RITUXIMAB;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
ANTIGENICITY;
B LYMPHOCYTE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG RESEARCH;
HUMAN;
HYBRID CELL;
HYBRIDOMA;
IMMUNOGENICITY;
IMMUNOSURVEILLANCE;
NONHUMAN;
PHAGE DISPLAY;
PRIORITY JOURNAL;
REVIEW;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BIOTECHNOLOGY;
CLINICAL TRIALS;
DRUG APPROVAL;
HUMANS;
TIME FACTORS;
|
|
EID: 0034873973
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt0901-819 Document Type: Review |
|
Times cited : (160)
|
|
References (8)
|
